NRX Pharmaceuticals Inc [NRXP] stock prices are up 3.54% to $2.34 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The NRXP shares have gain 8.84% over the last week, with a monthly amount drifted -1.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
NRX Pharmaceuticals Inc [NASDAQ: NRXP] stock has seen the most recent analyst activity on September 08, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $40. Previously, BTIG Research started tracking the stock with Buy rating on April 02, 2025, and set its price target to $18.
The stock price of NRX Pharmaceuticals Inc [NRXP] has been fluctuating between $1.58 and $3.90 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. NRX Pharmaceuticals Inc [NASDAQ: NRXP] shares were valued at $2.34 at the most recent close of the market. An investor can expect a potential drop of -14.53% based on the average NRXP price forecast.
Analyzing the NRXP fundamentals
Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -62.95%, Pretax Profit Margin comes in at -157.28%, and Net Profit Margin reading is -157.28%. To continue investigating profitability, this company’s Return on Assets is posted at -2.54, Equity is 1.39 and Total Capital is 0.6. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that NRX Pharmaceuticals Inc [NASDAQ:NRXP]’s Current Ratio is 0.29. On the other hand, the Quick Ratio is 0.29, and the Cash Ratio is 0.18. Considering the valuation of this stock, the price to sales ratio is 288.65.
